Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Impact of obefazimod on viral persistence, inflammation, and immune activation in people with HIV on suppressive antiretroviral therapy.
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis.
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study.
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.
in pork industry workers, Catalonia, Spain.
Impact of antibiotic treatment on the gut microbiome and its resistome in hematopoietic stem cell transplant recipients.
Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses.
Probiotic effects on immunity and microbiome in HIV-1 discordant patients.
Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut Microbiome.